SEC Form 4 · accession 0001358403-17-000142
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan K. Smith
Officer — EVP, Technical Operations
Period of report
Jul 24, 2017
Accepted (ET)
Jul 26, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 24, 2017 | S | 437 | $11.85 | D | 1,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2017 by the Reporting Person.
- F2Includes 1,163 shares acquired by the Reporting Person under the Issuer's 2014 Employee Stock Purchase Plan on June 9, 2017.